Earnings Feed
Start Free
Teladoc Health, Inc.·4

Mar 3, 4:08 PM ET

Bliss Kelly 4

Research Summary

AI-generated summary

Updated

Teladoc (TDOC) President Kelly Bliss Sells 26,647 Shares

What Happened

  • Kelly Bliss, President, U.S. Group Health at Teladoc (TDOC), had multiple equity award conversions/vestings and a small open‑market sale. On Feb 27, 2026 several derivative awards were converted/treated as exercised (totaling multiple blocks: 3,488; 4,858; 36,610; 1,186; 5,198 shares). On March 1, 2026 she was recorded as receiving 181,661 award units and earning 27,458 performance stock units. On March 2, 2026 she sold 26,647 shares in the open market at $5.12 per share, generating $136,353 in proceeds.
  • The conversions/exercises show $0 cash proceeds in the filing, indicating these were vestings/conversions of restricted stock units (RSUs) and performance stock units (PSUs), not cash option sales. The March 2 sale was a cash sale.

Key Details

  • Transaction dates and prices:
    • Feb 27, 2026: Multiple derivative exercises/conversions (3,488; 4,858; 36,610; 1,186; 5,198 shares) — listed with $0 proceeds (vest/convert).
    • Mar 1, 2026: Grant/award recorded for 181,661 units (acquired at $0.00); 27,458 PSUs earned (per footnote).
    • Mar 2, 2026: Open-market sale of 26,647 shares at $5.12/share = $136,353 proceeds.
  • Shares sold to cover taxes: Footnote F3 states the sale(s) were shares sold to cover the tax withholding obligation related to vesting of PSU/RSU awards.
  • Vesting notes: PSUs and RSUs convert one‑for‑one to common shares (F1, F2, F8, F12). Many awards vest one‑third on the indicated date (e.g., March 1, 2026) with the remainder vesting in eight substantially equal quarterly installments (F10, F11, F13).
  • Shares owned after transaction: Not specified in the excerpt provided.
  • Filing timeliness: Form 4 was filed March 3, 2026. The filing includes no indication of a late filing.

Context

  • These filings reflect routine vesting and tax‑withholding related sales rather than a directional open‑market investment decision. The $136k sale corresponds to withholding/settlement of awards rather than a large discretionary liquidation. Conversions labeled as "M" or with $0 proceeds are best read as RSU/PSU vesting or conversion to common shares (one‑for‑one), not taxable option cash exercises.